{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:19:54Z","timestamp":1780319994734,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1124\/jpet.114.216556","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T05:50:26Z","timestamp":1407390626000},"page":"181-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["HIS-388, a Novel Orally Active and Long-Acting 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models"],"prefix":"10.1016","volume":"351","author":[{"given":"Seiji","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokatsu","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Kainoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.216556_bib1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.114.216556_bib2","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/en.2003-0344","article-title":"Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains","volume":"144","author":"Alberts","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.114.216556_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?","volume":"62","author":"Anagnostis","year":"2013","journal-title":"Metabolism"},{"key":"10.1124\/jpet.114.216556_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1043-2760(03)00024-9","article-title":"The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones","volume":"14","author":"Arner","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/jpet.114.216556_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbrc.2007.11.032","article-title":"Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model","volume":"365","author":"Bhat","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.216556_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1874467211205020272","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) agonists on glycemic control, lipid profile and cardiovascular risk","volume":"5","author":"Derosa","year":"2012","journal-title":"Curr Mol Pharmacol"},{"key":"10.1124\/jpet.114.216556_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/jpet.114.216556_bib8","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1016\/S0021-9258(18)31478-9","article-title":"Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes","volume":"268","author":"Friedman","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.216556_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003495-200060020-00009","article-title":"Pioglitazone","volume":"60","author":"Gillies","year":"2000","journal-title":"Drugs"},{"key":"10.1124\/jpet.114.216556_bib10","doi-asserted-by":"crossref","first-page":"e74699","DOI":"10.1371\/journal.pone.0074699","article-title":"Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis","volume":"8","author":"Goto","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.114.216556_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tem.2010.06.004","article-title":"Will treating diabetes with 11\u03b2-HSD1 inhibitors affect the HPA axis?","volume":"21","author":"Harno","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/jpet.114.216556_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.114.216556_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1124\/jpet.114.216556_bib14","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11beta-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.216556_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1079\/BJN20031067","article-title":"Species differences in the physiological activity of dietary lignan (sesamin and episesamin) in affecting hepatic fatty acid metabolism","volume":"91","author":"Kushiro","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1124\/jpet.114.216556_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0006-291X(02)00822-7","article-title":"Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats","volume":"296","author":"Lee","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.114.216556_bib17","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.216556_bib18","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1210\/jc.2002-030017","article-title":"Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians","volume":"88","author":"Lindsay","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.114.216556_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0026-0495(98)90027-0","article-title":"Nongenetic mouse models of non-insulin-dependent diabetes mellitus","volume":"47","author":"Luo","year":"1998","journal-title":"Metabolism"},{"key":"10.1124\/jpet.114.216556_bib20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.114.216556_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI17845","article-title":"Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice","volume":"112","author":"Masuzaki","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.216556_bib22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/414821a","article-title":"New drug targets for type 2 diabetes and the metabolic syndrome","volume":"414","author":"Moller","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.114.216556_bib23","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.114.216556_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2009.09.027","article-title":"Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes","volume":"623","author":"Mu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.114.216556_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI1235","article-title":"Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats","volume":"101","author":"Okuno","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.216556_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bcp.2011.01.020","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)","volume":"81","author":"Park","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.114.216556_bib27","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.114.216556_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.bjp.0706041","article-title":"The dual PPARalpha\/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats","volume":"144","author":"Pickavance","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.114.216556_bib29","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.114.216556_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2210-8-3","article-title":"Inhibition of 11betaHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice","volume":"8","author":"Sundbom","year":"2008","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.114.216556_bib31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/db10-0830","article-title":"Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 \u03b2-hydroxysteroid dehydrogenase type 1-deficient mice","volume":"60","author":"Wamil","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/jpet.114.216556_bib32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00125-006-0239-y","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice","volume":"49","author":"Wang","year":"2006","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.114.216556_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1124\/jpet.114.216556_bib34","doi-asserted-by":"crossref","first-page":"943614","DOI":"10.1155\/2008\/943614","article-title":"Renal and vascular mechanisms of thiazolidinedione-induced fluid retention","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524188155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524188155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.216556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:50:09Z","timestamp":1739987409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524188155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022356524188155"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.216556","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIS-388, a Novel Orally Active and Long-Acting 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Ameliorates Insulin Sensitivity and Glucose Intolerance in Diet-Induced Obesity and Nongenetic Type 2 Diabetic Murine Models","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.216556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}